Skip to content
10-K

Annual Report

AVITA MEDICAL, INC. AVHHL RCEL

0001193125-26-049031

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 6, 2026 30.63M sh
Shares Diluted FY 2025 · Dec 31, 2025 27.86M sh
Shares Diluted FY 2025 · Dec 31, 2024 25.88M sh
Capex FY 2025 · Dec 31, 2025 $1.01M
Capex FY 2025 · Dec 31, 2024 $9.17M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$31.2M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$48.94M
Long Term Debt FY 2025 · Dec 31, 2025 $0
Long Term Debt FY 2025 · Dec 31, 2024 $42.25M
Short Term Debt FY 2025 · Dec 31, 2025 $42.98M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $10.24M
Cash And Equivalents FY 2025 · Dec 31, 2024 $14.05M
Stockholders Equity FY 2025 · Dec 31, 2025 −$16.65M
Stockholders Equity FY 2025 · Dec 31, 2024 $4.5M
Stockholders Equity FY 2025 · Dec 31, 2023 $49.06M
Current Liabilities FY 2025 · Dec 31, 2025 $62.68M
Current Liabilities FY 2025 · Dec 31, 2024 $20.16M
Total Liabilities FY 2025 · Dec 31, 2025 $73.04M
Total Liabilities FY 2025 · Dec 31, 2024 $74.97M
Current Assets FY 2025 · Dec 31, 2025 $35.49M
Current Assets FY 2025 · Dec 31, 2024 $57M
Total Assets FY 2025 · Dec 31, 2025 $56.39M
Total Assets FY 2025 · Dec 31, 2024 $79.71M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.74
Eps Diluted FY 2025 · Dec 31, 2024 −$2.39
Eps Basic FY 2025 · Dec 31, 2025 −$1.74
Eps Basic FY 2025 · Dec 31, 2024 −$2.39
Sga Expense FY 2025 · Dec 31, 2025 $27.37M
Sga Expense FY 2025 · Dec 31, 2024 $33.2M
Rd Expense FY 2025 · Dec 31, 2025 $20.84M
Rd Expense FY 2025 · Dec 31, 2024 $20.36M
Net Income FY 2025 · Dec 31, 2025 −$48.59M
Net Income FY 2025 · Dec 31, 2024 −$61.85M
Operating Income FY 2025 · Dec 31, 2025 −$42.53M
Operating Income FY 2025 · Dec 31, 2024 −$56.59M
Gross Profit FY 2025 · Dec 31, 2025 $58.82M
Gross Profit FY 2025 · Dec 31, 2024 $55.16M
Cost Of Revenue FY 2025 · Dec 31, 2025 $12.79M
Cost Of Revenue FY 2025 · Dec 31, 2024 $9.09M
Revenue FY 2025 · Dec 31, 2025 $71.61M
Revenue FY 2025 · Dec 31, 2024 $64.25M